UK's Medicines Discovery Catapult Launches Call for Collaboration for SMEs

Nov 01, 2017
By Pharmaceutical Executive Editors
Medicines Discovery Catapult, a new UK center established to support innovative drug discovery, is inviting UK SMEs working in medicines to collaborate on high-resolution analysis.
 
On offer is access to an atomic resolution Solid State NMR (SSNMR) at Medicines Discovery Catapult’s facility within the University of Warwick, along with world-leading scientific support, including data analysis and interpretation. Through this Call Medicines Discovery Catapult aims to provide atomic resolution of a compound, protein structure or complex and its dynamic interactions, which are not normally amenable to resolution by other approaches.
 
UK-registered micro, small or medium-sized enterprises engaged in drug discovery and drug re-purposing are invited to apply by Thursday November 30.
 
Dr Peter Simpson, Chief Scientific Officer of Medicines Discovery Catapult commented: “We’re looking for innovative, dynamic partners with technically feasible proposals that will bring about significant new advances. This is an excellent opportunity for a UK SME to accelerate their R&D.”
 
 
 
native1_300x100
lorem ipsum